TrialThe Journal of infectious diseases2022

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.

Jerald Sadoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.